TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer,...
Read more
New data presented showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of...
Read more
Boehringer Ingelheim and MiNA Therapeutics (“MiNA”), a pioneer in RNA activation therapeutics, announced that they have signed a collaboration and...
Read more
Median Technologies, The Imaging Phenomics Company® (ALMDT:PA) is pleased to announce that James Golando, Chief of Operations at Median Technologies...
Read more
Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative...
Read more
Adaptive Biotechnologies, a leader in combining next-generation sequencing (NGS) and sophisticated bioinformatics to profile T- and B-cell receptors of the...
Read more
Dermira, Inc and UCB announced the companies have agreed to end their development and commercialization agreement for CIMZIA (certolizumab pegol)...
Read more
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation...
Read more
PCI Pharma Services is excited to announce further market leading investment in fully contained Xcelodose® 600S technology at our center...
Read moreHalozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen Biotech, Inc. has initiated...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
